Guardant, Dexcom, and Insulet nailed their quarters and have massive room to grow in the long run, too.
Shares pop after news breaks that the company is joining an index. Here are the key details for investors.
Shares jump after the medical device maker announces that it has secured an important regulatory win.
Shares sink after the company announces mixed third-quarter results and issues disappointing guidance.
These companies have a lot to offer their patients and plenty of room to grow.
The stroke prevention specialist is growing rapidly and has a huge opportunity ahead of it. Should investors get on board?
The current transportation process is riddled with inefficiencies and waste. TransMedics is on a mission to fix the problem and deliver huge returns for investors.
The supply chain software provider has grown like a weed over the past decade, but is this company built to last?
How does the supply chain specialist keep rivals at bay?
Shares pop after the company reports impressive third-quarter results.
Shares rose by double digits after the company reported expectation-smashing third-quarter results and issued bullish guidance.
The medical device winner just keeps on winning.
Shares jumped following upbeat third-quarter results and a guidance boost.
Shares slump after the company reports weak third-quarter results and cuts guidance. Here's what investors need to know.
Shares jump after the company accepts a buyout offer.
Shares drop after the company reports mixed third-quarter results. Here's what investors need to know.
These newly public companies have some big potential to change lives and reward investors.
Shares jump in response to better-than-expected earnings and bullish guidance.
Shares tumble after an FDA advisory committee recommends pulling one of the company's key drugs from the market. Here are the must-know details.
Shares shed more than a third of their value after the company's third-quarter earnings and guidance come up short.